The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

EuroIntervention 2021;16:1129-1130. DOI: 10.4244/EIJV16I14A203

1. University Hospital Brno, Faculty of Medicine of Masaryk University, Brno, Czech Republic


Primary percutaneous coronary intervention (PPCI) has been the preferred reperfusion strategy for patients with ST-elevation myocardial infarction (STEMI). However, in 2020, intravenous thrombolysis still remains a viable option for reperfusion. In European countries, long transportation time to PPCI has been the main indication for thrombolysis. Current clinical practice guidelines highlight the importance of the time interval from the first medical contact to the catheterisation laboratory admission1. If this is more than 120 minutes, a thrombolytic agent has to be administered first, followed by transport to the nearest catheterisation laboratory. Invasive assessment of the coronary arteries should be performed within 2-24 hours ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve